These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 32087930)
1. The neoepitopes on methylglyoxal (MG) glycated LDL create autoimmune response; autoimmunity detection in T2DM patients with varying disease duration. Khan MY; Alouffi S; Khan MS; Husain FM; Akhter F; Ahmad S Cell Immunol; 2020 May; 351():104062. PubMed ID: 32087930 [TBL] [Abstract][Full Text] [Related]
2. Antigenic role of the adaptive immune response to d-ribose glycated LDL in diabetes, atherosclerosis and diabetes atherosclerotic patients. Akhter F; Khan MS; Alatar AA; Faisal M; Ahmad S Life Sci; 2016 Apr; 151():139-146. PubMed ID: 26874030 [TBL] [Abstract][Full Text] [Related]
3. The Neoepitopes on Methylglyoxal- (MG-) Glycated Fibrinogen Generate Autoimmune Response: Its Role in Diabetes, Atherosclerosis, and Diabetic Atherosclerosis Subjects. Rehman S; Song J; Faisal M; Alatar AA; Akhter F; Ahmad S; Hu B Oxid Med Cell Longev; 2021; 2021():6621568. PubMed ID: 34970417 [TBL] [Abstract][Full Text] [Related]
4. Detection of Circulating Auto-Antibodies Against Ribosylated-LDL in Diabetes Patients. Akhter F; Salman Khan M; Faisal M; Alatar AA; Ahmad S J Clin Lab Anal; 2017 Mar; 31(2):. PubMed ID: 27561427 [TBL] [Abstract][Full Text] [Related]
5. Generation of autoantibodies against glycated fibrinogen: Role in diabetic nephropathy and retinopathy. Khanam A; Alouffi S; Alyahyawi AR; Husain A; Khan S; Alharazi T; Akasha R; Khan H; Shahab U; Ahmad S Anal Biochem; 2024 Jan; 685():115393. PubMed ID: 37977213 [TBL] [Abstract][Full Text] [Related]
6. Methylglyoxal mediated glycation leads to neo-epitopes generation in fibrinogen: Role in the induction of adaptive immune response. Rehman S; Alouffi S; Faisal M; Qahtan AA; Alatar AA; Ahmad S Int J Biol Macromol; 2021 Apr; 175():535-543. PubMed ID: 33529635 [TBL] [Abstract][Full Text] [Related]
7. Characterization of Glyoxal Modified LDL: Role in the Generation of Circulating Autoantibodies in Type 2 Diabetes Mellitus and Coronary Artery Disease. Rizwee MM; Abidi M; Habib S; Mir AR; Ali A; Uddin M Curr Drug Deliv; 2021; 18(7):1027-1040. PubMed ID: 34911421 [TBL] [Abstract][Full Text] [Related]
8. Autoimmune response to advanced glycosylation end-products of human LDL. Virella G; Thorpe SR; Alderson NL; Stephan EM; Atchley D; Wagner F; Lopes-Virella MF; J Lipid Res; 2003 Mar; 44(3):487-93. PubMed ID: 12562876 [TBL] [Abstract][Full Text] [Related]
9. Prevalence of auto-antibodies against D-ribose-glycated-hemoglobin in diabetes mellitus. Siddiqui Z; Faisal M; Alatar AR; Ahmad S Glycobiology; 2019 May; 29(5):409-418. PubMed ID: 30834437 [TBL] [Abstract][Full Text] [Related]
10. Neo-epitopes on methylglyoxal modified human serum albumin lead to aggressive autoimmune response in diabetes. Jyoti ; Mir AR; Habib S; Siddiqui SS; Ali A; Moinuddin Int J Biol Macromol; 2016 May; 86():799-809. PubMed ID: 26861824 [TBL] [Abstract][Full Text] [Related]
11. Methylglyoxal modified IgG generates autoimmune response in rheumatoid arthritis. Islam S; Mir AR; Abidi M; Talha M; Zafar A; Habib S; Moinuddin Int J Biol Macromol; 2018 Oct; 118(Pt A):15-23. PubMed ID: 29906533 [TBL] [Abstract][Full Text] [Related]
12. Studies on glycoxidatively modified human IgG: Implications in immuno-pathology of type 2 diabetes mellitus. Islam S; Moinuddin ; Mir AR; Arfat MY; Alam K; Ali A Int J Biol Macromol; 2017 Nov; 104(Pt A):19-29. PubMed ID: 28583871 [TBL] [Abstract][Full Text] [Related]
13. Neo-Epitopes Generated on Hydroxyl Radical Modified GlycatedIgG Have Role in Immunopathology of Diabetes Type 2. Islam S; Mir AR; Raghav A; Khan F; Alam K; Ali A; Uddin M PLoS One; 2017; 12(1):e0169099. PubMed ID: 28046123 [TBL] [Abstract][Full Text] [Related]
14. Serum Levels of Antibodies to Advanced Glycation End Products in Patients with Type 2 Diabetes Mellitus and Hypertension. Nikolov A; Blazhev A; Tzekova M; Kostov K; Popovski N Folia Med (Plovdiv); 2020 Jun; 62(2):295-301. PubMed ID: 32666760 [TBL] [Abstract][Full Text] [Related]
15. Nonenzymatic glycosylation of human serum albumin and its effect on antibodies profile in patients with diabetes mellitus. Raghav A; Ahmad J; Alam K PLoS One; 2017; 12(5):e0176970. PubMed ID: 28520799 [TBL] [Abstract][Full Text] [Related]
16. Biophysical changes in methylglyoxal modified fibrinogen and its role in the immunopathology of type 2 diabetes mellitus. Perween S; Abidi M; Faiz Faizy A; Moinuddin Int J Biol Macromol; 2022 Mar; 202():199-214. PubMed ID: 34999047 [TBL] [Abstract][Full Text] [Related]
18. Definition of the immunogenic forms of modified human LDL recognized by human autoantibodies and by rabbit hyperimmune antibodies. Virella G; Thorpe SR; Alderson NL; Derrick MB; Chassereau C; Rhett JM; Lopes-Virella MF J Lipid Res; 2004 Oct; 45(10):1859-67. PubMed ID: 15258197 [TBL] [Abstract][Full Text] [Related]
19. Identification of Glycoxidative Lesion in Isolated Low-Density Lipoproteins from Diabetes Mellitus Subjects. Alyahyawi AR; Khan MY; Alouffi S; Maarfi F; Akasha R; Khan S; Rafi Z; Alharazi T; Shahab U; Ahmad S Life (Basel); 2023 Sep; 13(10):. PubMed ID: 37895368 [TBL] [Abstract][Full Text] [Related]
20. Non-enzymatic glucosylation induced neo-epitopes on human serum albumin: A concentration based study. Neelofar K; Arif Z; Ahmad J; Alam K PLoS One; 2017; 12(2):e0172074. PubMed ID: 28192530 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]